| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/18/2010 | US20100040707 Ingestible compositions containing extracts |
| 02/18/2010 | US20100040700 Kit for promoting hair growth |
| 02/18/2010 | US20100040629 Antibodies to c-Met |
| 02/18/2010 | US20100040604 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 02/18/2010 | US20100040568 Steroidal compounds as melanogenesis modifiers and uses thereof |
| 02/18/2010 | CA2735562A1 Organic compounds for wound healing |
| 02/18/2010 | CA2734389A1 S0x9, prostaglandin d2 and retinoic acid for treating pigmentary conditions and melanoma |
| 02/18/2010 | CA2733926A1 Therapeutic compounds |
| 02/18/2010 | CA2733642A1 Anti-il-12/il-23 antibodies |
| 02/18/2010 | CA2730716A1 Composite particles having an antioxidant-based protective system, and topical compositions comprising the same |
| 02/17/2010 | EP2154149A1 A truncated l1 protein of human papillomavirus 6 |
| 02/17/2010 | EP2154148A1 A truncated l1 protein of human papillomavirus 11 |
| 02/17/2010 | EP2153836A1 Film-forming liquid formulations for drug release to hair and scalp |
| 02/17/2010 | EP2153736A1 Novel leukotriene receptor antagonist |
| 02/17/2010 | EP2152299A2 Pharmaceutical and/or cosmetic composition containing aconitase-activating active ingredients |
| 02/17/2010 | EP2152257A1 Diabetic wound healing |
| 02/17/2010 | EP2152256A2 Telomerase activating compounds and methods of use thereof |
| 02/17/2010 | EP2049092B1 Compositions with enhanced elasticizing activity |
| 02/17/2010 | EP1675603B9 Use of probiotic bacteria in the treatment of infection |
| 02/17/2010 | EP1511737B1 Aryloximes |
| 02/17/2010 | CN201404486Y Controlled-release micro sphere of chitosan coating 3,5-dyhydroxy-4-isopropyl toluylene |
| 02/17/2010 | CN100590124C Tricyclic androgen receptor modulator compounds and method |
| 02/17/2010 | CN100589809C Quaternised ammonium cyclodextrin compounds |
| 02/17/2010 | CN100589790C Cosmetic for depigmentation |
| 02/16/2010 | US7662974 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 02/16/2010 | US7662948 Antisense oligonucleotides against VR1 |
| 02/16/2010 | US7662854 HIF hydroxylase inhibitors |
| 02/16/2010 | US7662851 Use of specific cyklolignans |
| 02/16/2010 | US7662849 N-cyanomethyl-2R-[(benzenesulfonyliminomethyl)amino]-3-(2-difluoromethoxyphenylmethanesulfonyl)-propionamide; treating autoimmune disorders |
| 02/16/2010 | US7662845 2,5-Dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase MMP12 |
| 02/16/2010 | US7662843 Isoxazoline compounds having MIF antagonist activity |
| 02/16/2010 | US7662825 2,3-Dichloro-N-(3-methoxy-5-methyl-2-pyrazinyl)-benzenesulphonamide; inflammatory diseases, such as asthma |
| 02/16/2010 | US7662814 4-(4-Ethylpiperazin-1-yl)-5-methyl-2-phenylthieno[2,3-d]pyrimidine-6-carbonitrile; asthma, atopic dermatitis, chronic obstructive pulmonary disease, Crohn's disease, type I and type II diabetes, lymphoid leukemia and other forms of cancer, multiple sclerosis and autoimmune diseases |
| 02/16/2010 | US7662807 Sulphonated meso-tetraphenyl chlorins |
| 02/16/2010 | US7662794 DNA enzyme to inhibit plasminogen activator inhibitor-1 |
| 02/16/2010 | US7662782 Melanocortin 1 receptor selective compounds |
| 02/16/2010 | US7662548 Method of screening for modulators of HIV infection |
| 02/16/2010 | US7662365 Polymer conjugates of opioid antagonists |
| 02/16/2010 | CA2478183C Substituted amides |
| 02/16/2010 | CA2402436C Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 02/16/2010 | CA2308551C Phenanthroline derivatives |
| 02/11/2010 | WO2010016509A1 Stable pharmaceutical composition containing tranexamic acid and ascorbic acid |
| 02/11/2010 | WO2010015965A2 Methods and compositions for treating neuronal damage and modulating transient receptor potential channels |
| 02/11/2010 | WO2010015870A1 Use of dihydralazine for the treatment of diseases related to elevated semicarbazide sensitive amine-oxidase (ssao) activity |
| 02/11/2010 | WO2010015792A1 Nitrogen containing heterocyclic compounds useful as bifunctional modulators of m3 receptors and beta-2 receptors |
| 02/11/2010 | WO2010015520A1 Substituted naphthyridines and use thereof as medicines |
| 02/11/2010 | WO2009157858A8 Use of cyclolignans for the treatment of a hyperactive immune system |
| 02/11/2010 | WO2009155070A3 Compositions and methods for treatment of inflammation and hyperkeratotic lesions |
| 02/11/2010 | WO2009131395A3 Angiogenic peptide |
| 02/11/2010 | US20100035943 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors |
| 02/11/2010 | US20100035916 Azabicycloalkane derivatives, preparation thereof and use thereof in therapy |
| 02/11/2010 | US20100035908 Substituted acetophenones useful as pde4 inhibitors |
| 02/11/2010 | US20100035903 administering 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile or salts, for the treatment of dermatitis, Crohn's disease, inflammatory bowel disease, transplant rejection, lupus, multiple sclerosis, arthritis, psoriasis, diabetes and autoimmune diseases |
| 02/11/2010 | US20100035891 Pharmaceutically Active Compounds |
| 02/11/2010 | US20100035870 Pyrimidin-4-yl-3, 4-Dihydro-2H-Pyrrolo[1,2A] Pyrazin-1-one Compounds |
| 02/11/2010 | US20100035842 Amino alcohol compounds or phosphonic acid derivatives thereof |
| 02/11/2010 | US20100035831 Anti-wrinkle agent and adam inhibitor |
| 02/11/2010 | US20100035819 Method of promoting skin collagen production |
| 02/11/2010 | US20100035816 Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency or oxidative stress or skin ageing or dry skin |
| 02/11/2010 | US20100035815 Skin wound healing compositions and methods of use thereof |
| 02/11/2010 | US20100035801 Method for accelerating cutaneous barrier recovery |
| 02/11/2010 | US20100035798 Methods and compositions for the topical oxygenation of hypoxic tissue |
| 02/11/2010 | US20100035796 17-alpha-substituted derivatives of estradiol with wound-healing activity |
| 02/11/2010 | US20100035793 Modulators |
| 02/11/2010 | US20100034853 Compositions of activated botulinum toxin type B |
| 02/11/2010 | US20100034823 Crystalline anti-hTNFalpha antibodies |
| 02/11/2010 | US20100034771 Combination Of Cytokine And Cytokine Receptor For Altering Immune System Functioning |
| 02/11/2010 | US20100034768 Composition and method for treatment of insect bites |
| 02/11/2010 | CA2732087A1 Substituted naphthyridines and their use as medicaments |
| 02/11/2010 | CA2725012A1 Methods for treating injury associated with exposure to an alkylating species |
| 02/10/2010 | EP2151436A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity |
| 02/10/2010 | EP2151241A1 Stable solid preparation comprising 4,5-epoxymorphinan derivative |
| 02/10/2010 | EP2150267A1 Pharmaceutical and/or cosmetic composition containing a cytochrome c-activating active ingredient |
| 02/10/2010 | EP2150266A1 Pharmaceutical and/or cosmetic composition containing an active ingredient which is antioxidant and which activates cell energy |
| 02/10/2010 | EP2150262A2 Use of vernonia appendiculata extract for improving the skin status |
| 02/10/2010 | EP1525191B1 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 02/10/2010 | EP1490365B1 Azaindoles as inhibitors of c-jun n-terminal kinases |
| 02/10/2010 | CN101642458A Use of cyclopamine in the treatment of psoriasis and other skin disorders |
| 02/10/2010 | CN100588649C Method for producing condensed imidazole compound, reformatsky reagent having stable form and production thereof |
| 02/10/2010 | CN100588647C Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 02/09/2010 | US7659407 Pharmaceutical compounds |
| 02/09/2010 | US7659367 Contains insulin-like growth factor-I, insulin-like growth factor binding protein 3 and integrin-binding domain of vitronectin ; wound healing; surgical implant, prosthesis, scaffold, wound or burn dressing |
| 02/09/2010 | US7659303 Reduce tumor necrosis factor; phosphodiesterase inhibitor; antiinflammatory agents; anticancer agents; antidepressants; skin diosrders |
| 02/09/2010 | US7659302 Methods of using (+)-2-[1-(3-ethoxy-4 methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione |
| 02/09/2010 | US7659293 α-Amino-N-hydroxy-acetamide derivatives |
| 02/09/2010 | US7659272 N-[phenyl or heteroaryl carbonoyl pyridyl] arylsulfonamides; antiinflammatory, antianaphylactic agents; transplant rejection, gastointestinal, respriatory system and skin disorders |
| 02/09/2010 | CA2484954C 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 02/09/2010 | CA2482320C Methods for modulating phototoxicity |
| 02/09/2010 | CA2473394C Semi-fluorinated alkanes and their use |
| 02/09/2010 | CA2466720C Medicament for the treatment of viral skin and tumour diseases |
| 02/09/2010 | CA2440760C Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 02/09/2010 | CA2438704C Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 02/09/2010 | CA2414921C Use of diclofenac for treatment of burns |
| 02/09/2010 | CA2413061C Serine protease inhibitors |
| 02/09/2010 | CA2389688C A method of microencapsulation |
| 02/09/2010 | CA2386297C Bicyclic amino acids as pharmaceutical agents |
| 02/09/2010 | CA2349875C Dna encoding a growth factor specific for epithelial cells |
| 02/08/2010 | CA2672181A1 Adhesive patch for protecting and treating viral cutaneous lesions |
| 02/04/2010 | WO2010014839A1 Betalain compositions and uses thereof |
| 02/04/2010 | WO2010013595A1 (5-membered)-(5-membered) or (5-membered)-(6-membered) fused ring cycloalkylamine derivative |